Bristol-Myers Opts To Drop Suit Rather Than Publish Award
Bristol-Myers Squibb Co. has decided to quietly dismiss its lawsuit seeking to enforce an arbitral award it won in a fight with Novartis Pharma AG over transgenic mice rather than be...To view the full article, register now.
Already a subscriber? Click here to view full article